Eli Lilly reports tirzepatide MASH success during Q4 earnings

DarronCummings/APTheblockbusterweightlossanddiabetesdrugsoldbyEliLillyalsoappearstoimprovefattyliver MollyFergusonforSTATWhencyclistAlisonTetrickjoinedthesport’sprofessionalranks,shereceivedtheperkstha




hotspot

author：explore    Page View：7

Editor’s note: A livestream of the event is embedded below.

Enough talk about fairness, safety, and effectiveness. If we want AI systems to possess these attributes in health care, we have to test them with those goals in mind.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In
Previous article： Readout Newsletter: Amylyx, Aurinia, and IQVIA
Next article： Psychedelics group wrestles with new pharma identity